治疗心脏代谢综合征：提供全面降低心血管风险的契机。 - Suppr

Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

作者信息

Basile Jan, Houston Mark, Ferrario Carlos M

机构信息

Ralph H. Johnson VA Medical Center and Division of General Internal Medicine/Geriatrics, Medical University of South Carolina, Charleston, SC 29401, USA.

出版信息

J Cardiometab Syndr. 2006 Fall;1(5):358-61. doi: 10.1111/j.1559-4564.2006.06035.x.

DOI:10.1111/j.1559-4564.2006.06035.x

PMID:17679795

Abstract

摘要

相似文献

Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

J Cardiometab Syndr. 2006 Fall;1(5):358-61. doi: 10.1111/j.1559-4564.2006.06035.x.

Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.

J Cardiometab Syndr. 2006 Spring;1(2):133-40. doi: 10.1111/j.1559-4564.2006.05487.x.

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.

Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40. doi: 10.1097/HJR.0b013e3283383f30.

Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.

Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):532-41. doi: 10.1016/j.numecd.2008.11.004. Epub 2009 Mar 25.

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. doi: 10.1097/01.hjr.0000277983.23934.c9.

Management of hypertension in children and adolescents with the metabolic syndrome.

J Cardiometab Syndr. 2006 Summer;1(4):259-68. doi: 10.1111/j.1559-4564.2006.05801.x.

Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.

Cardiovasc J Afr. 2009 Jan-Feb;20(1):73-4.

Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?

J Cardiometab Syndr. 2006 Spring;1(2):146-8. doi: 10.1111/j.1559-4564.2006.05527.x.

Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".

J Vasc Surg. 2008 Sep;48(3):776-7; author reply 777. doi: 10.1016/j.jvs.2008.04.074.

Present recommendations in type 2 diabetes treatment.

Endocrinol Nutr. 2009 Dec;56 Suppl 4:46-9.

引用本文的文献

Does the Naked Emperor Parable Apply to Current Perceptions of the Contribution of Renin Angiotensin System Inhibition in Hypertension?

Curr Hypertens Rep. 2022 Dec;24(12):709-721. doi: 10.1007/s11906-022-01229-x. Epub 2022 Oct 22.

Meta-Analysis of the Effects of Foods and Derived Products Containing Ellagitannins and Anthocyanins on Cardiometabolic Biomarkers: Analysis of Factors Influencing Variability of the Individual Responses.

Int J Mol Sci. 2018 Feb 28;19(3):694. doi: 10.3390/ijms19030694.

Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.

Integr Blood Press Control. 2014 Nov 26;7:61-70. doi: 10.2147/IBPC.S50954. eCollection 2014.

Impact of performance improvement continuing medical education on cardiometabolic risk factor control: the COSEHC initiative.

J Contin Educ Health Prof. 2014 Winter;34(1):25-36. doi: 10.1002/chp.21217.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

作者信息

Basile Jan, Houston Mark, Ferrario Carlos M

机构信息

Ralph H. Johnson VA Medical Center and Division of General Internal Medicine/Geriatrics, Medical University of South Carolina, Charleston, SC 29401, USA.

出版信息

J Cardiometab Syndr. 2006 Fall;1(5):358-61. doi: 10.1111/j.1559-4564.2006.06035.x.

DOI:10.1111/j.1559-4564.2006.06035.x

PMID:17679795

Abstract

摘要

Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

作者信息

机构信息

出版信息

相似文献

引用本文的文献